Compare · 2 funds side by side · dividends reinvested

SBIO and ARKG

SBIOALPS×ARKGARK×

Versus in desk

02 / 04

IWD+0.4%

Search ETFs and stocks

Portfolio

Story of the two · Growth5Y$10,000 five years agoDividends reinvested · both on one scale$12,211SBIO · best of the two

Story of the two · IncomeMost incomeSBIO · 0.00% · $0 a year on $10k

Story of the two · RiskSmallest drop

SBIO and ARKG, Ranked

Today

FundFeeYieldYTD1 year3 yrs · yr5 yrs · yrWorst dropVolatilityAssetsAvg rank

ALPS Medical Breakthroughs ETFSectors · Health care0.50%0.00%+13.7%+31.0%+33.2%+4.1%−29.2%33.4%$193M1.4

ARK Genomic Revolution ETFSectors · Health care0.75%0.00%+59.8%+62.3%+22.3%−9.9%−27.5%47.2%$2.2B1.5

Rank among the two1st → 2ndFee, drop and volatility: lower ranks higherAvg rank: mean of the 8 ranks · 1 is best

End-of-day Nov 11, 2026 · returns include dividends · since: SBIO 2014 · ARKG 2014

Head to Head

Swap sides Versus in desk

Head to Head

5Y

ALPS Medical Breakthroughs ETF · $193M$12,211

SBIO

ARKG

ARK Genomic Revolution ETF · $2.2B$5,949

$10,000 five years ago, dividends reinvested · they hold 2.1% in common

SBIOMeasureARKG

+13.7%

More Ways to See the Pairs

SBIO vs ARKG: Top 5 Holdings

Today

SBIO

19.0%in top 5

ARKG

in top 537.8%

SBIOStockARKG

not top 5TEM10.9%

not top 5TWST8.3%

not top 5TXG8.0%

not top 5ABSI5.5%

not top 5CRSP5.2%

Cost, Income and Risk

Fees: SBIO, ARKG

Today

0.50%lowest, SBIO

FundExpense ratioFee$10k

SBIO0.50%$50

ARKG0.75%$75

End-of-day Nov 11, 2026 · fee on $10,000 a year

Yields: SBIO, ARKG

1Y

0.00%highest, SBIO

FundTrailing yieldYield

Popular Pairs Near These Two

SCHD vs VIG

YTD

SchwabSCHD

+34.6%

VIGVanguard

+16.0%

+34.6%Year to date+16.0%

2.9%Yield1.4%

$123BAssets$109B

2–0SCHD wins

End-of-day Nov 11, 2026

JEPQ vs JEPI

YTD

J.P. MorganJEPQ

+8.1%

JEPIJ.P. Morgan

+8.6%

SPYM vs SPY

YTD

SPDRSPYM

+12.4%

SPYSPDR

+12.3%

Year to dateJan 1 → Nov 11

+59.8%

+31.0%1 yearTotal return+62.3%

+33.2%3 years · per year$10,000 became $23,657 · $18,292+22.3%

+4.1%5 years · per year$10,000 became $12,211 · $5,949−9.9%

0.50%Expense ratio$50 · $75 a year on $10k · lower is better0.75%

0.00%Trailing 12-mo yield$0 · $0 a year on $10k0.00%

−29.2%Worst dropSmaller is better−27.5%

33.4%VolatilityLower is calmer47.2%

SBIOARKG Winner of the row, in its colourEach row: the bigger of the two fills its side

4–3SBIO wins

End-of-day Nov 11, 2026 · returns include dividends · 3Y and 5Y figures are per-year returns

4.6%ORKAnot top 5

4.1%CGONnot top 5

3.9%MANEnot top 5

3.2%EWTXnot top 5

3.2%DNTHnot top 5

Held in common2.1%

End-of-day Nov 11, 2026 · share of each fund

SBIO vs ARKG Returns, Every Period

5Y

ALPSSBIO

+4.1%

5 years, per year

ARKGARK

−9.9%

5 years, per year

SBIOARKGFaded: behind in that period

2–2Level

End-of-day Nov 11, 2026 · dividends in · faded = behind in that period

SBIO vs ARKG

YTD

ALPSSBIO

+13.7%

ARKGARK

+59.8%

+13.7%Year to date+59.8%

−29.2%Worst drop · 1Y−27.5%

33.4%Volatility · 1Y47.2%

0.0%Yield0.0%

$193MAssets$2.2B

2–1ARKG wins

End-of-day Nov 11, 2026 · smaller drop and lower volatility win

$10k

SBIO0.00%$0

ARKG0.00%$0

End-of-day Nov 11, 2026 · trailing 12-month yield

Income After Fees on $10,000

1Y

−$50most kept, SBIO

SBIO$0 − $50 = −$50

ARKG$0 − $75 = −$75

KeptFee

End-of-day Nov 11, 2026 · yield in dollars minus the fee

Overlap: SBIO, ARKG

Today

2.1%most shared, SBIO and ARKG

SBIOARKG

SBIO—2.1%

ARKG2.1%—

End-of-day Nov 11, 2026 · share held in common · outlined: the pair in versus

Return vs Bumpiness: 2 ETFs

1Y

+62.3%ARKG, at 47.2% volatility

SBIOWorst drop−29.2%33.4% vol

ARKGWorst drop−27.5%47.2% vol

End-of-day Nov 11, 2026 · up and left is better

Paid More vs Made More

YTD

SBIOARKG

+13.7%Year to date+59.8%

0.0%Yield0.0%

+31.0%Past year+62.3%

0.50%Fee0.75%

2–1ARKG wins

End-of-day Nov 11, 2026

+8.1%Year to date+8.6%

12.2%Yield7.8%

$42.0BAssets$46.6B

1–1level

End-of-day Nov 11, 2026

+12.4%Year to date+12.3%

1.0%Yield1.0%

$183BAssets$792B

1–0SPYM wins

End-of-day Nov 11, 2026

Loading…

SBIO and ARKG

Head to Head

More Ways to See the Pairs

Cost, Income and Risk

Popular Pairs Near These Two